Search

Hui Shen Phones & Addresses

  • Palo Alto, CA
  • Mountain View, CA
  • Redwood City, CA
  • Brentwood, CA
  • San Jose, CA
  • Santa Clara, CA
  • Forest Hills, NY
  • Fremont, CA

Professional Records

Lawyers & Attorneys

Hui Shen Photo 1

Hui Shen - Lawyer

View page
Office:
Steptoe & Johnson LLP
Specialties:
Clean Energy Technology
Intellectual Property
Patent: Nanotechnologies
ISLN:
922023621
University:
Huazhong University of Science & Technology, B.S., 1998; Huazhong University of Science & Technology, B.S., 1998; Huazhong University of Science & Technology, M.S., 2001; Huazhong University of Science & Technology, M.S., 2001; University of Virginia, Ph.D., 2008

Medicine Doctors

Hui Shen Photo 2

Hui Wang Shen

View page
Specialties:
Psychiatry
Education:
National Defense Medical Center (1953)

Resumes

Resumes

Hui Shen Photo 3

Hui Shen

View page
Location:
United States

Business Records

Name / Title
Company / Classification
Phones & Addresses
Hui Shen
President
Enlighten Education, Inc
PO Box 321242, Los Gatos, CA 95032
120 Carlton Ave, Los Gatos, CA 95032
Hui Shen
President
Sunny Tech Electronics Inc
515 S Palm Ave, Alhambra, CA 91803
Hui Z. Shen
President
Z&S INVESTMENT, INC
Whol Brick/Stone Material · Investor
828 Nogales St, Rowland Heights, CA 91748
828 Nogales St, Whittier, CA 91748
365 W Garvey Ave, Monterey Park, CA 91754
Hui Shen
President
HL-DYNASTY INTERNATIONAL, INC
9300 Flair Dr #649, El Monte, CA 91731
Hui Shen
President
MXW TECHNOLOGIES INC
120 Carlton Ave STE 54, Los Gatos, CA 95032
Hui Chen Shen
President
BEYOND DESIGN, INC
900 Arcadia Ave STE 1, Arcadia, CA 91007
Hui Shen
President
OSTRICH TRADING INC
205 E Las Unas Dr, San Gabriel, CA 91776
205 E Las Tunas Dr, San Gabriel, CA 91776

Publications

Us Patents

Semi-Solid Delivery Vehicle And Pharmaceutical Compositions For Delivery Of Granisetron

View page
US Patent:
8252304, Aug 28, 2012
Filed:
Sep 22, 2009
Appl. No.:
12/564881
Inventors:
Steven Y. Ng - San Francisco CA, US
Hui Rong Shen - Fremont CA, US
Jorge Heller - Ashland OR, US
Assignee:
A. P. Pharma, Inc. - Redwood City CA
International Classification:
A61K 31/435
A61K 31/439
A61K 31/53
A61K 47/30
C07D 319/04
US Classification:
424426, 424486, 424422, 424425, 514279, 514337, 514338, 514339, 5147723, 549335
Abstract:
A semi-solid delivery vehicle contains a polyorthoester and an excipient, and a semi-solid pharmaceutical composition contains an active agent and the delivery vehicle. The pharmaceutical composition may be a topical, syringable, or injectable formulation; and is suitable for local delivery of the active agent. Methods of treatment are also disclosed.

Methods Of Treating Emesis Utilizing Semi-Solid Delivery Pharmaceutical Compositions Comprising Granisetron

View page
US Patent:
8252305, Aug 28, 2012
Filed:
Oct 24, 2011
Appl. No.:
13/279938
Inventors:
Steven Y. Ng - San Francisco CA, US
Hui Rong Shen - Fremont CA, US
Jorge Heller - Ashland OR, US
Assignee:
A.P. Pharma - Redwood City CA
International Classification:
A61K 31/439
A61K 31/435
A61K 31/46
A61K 31/416
A61K 47/30
A61P 1/08
C07D 319/04
US Classification:
424426, 424422, 424425, 424486, 514279, 514337, 514338, 514339, 5147723, 5147727, 549335
Abstract:
A semi-solid delivery vehicle contains a polyorthoester and an excipient, and a semi-solid pharmaceutical composition contains an active agent and the delivery vehicle. The pharmaceutical composition may be a topical, syringable, or injectable formulation; and is suitable for local delivery of the active agent. Methods of treatment are also disclosed.

Process For Preparing A Semi-Solid Delivery Vehicle Comprising Granisetron

View page
US Patent:
8252306, Aug 28, 2012
Filed:
Oct 24, 2011
Appl. No.:
13/279949
Inventors:
Steven Y. Ng - San Francsico CA, US
Hui Rong Shen - Fremont CA, US
Jorge Heller - Ashland OR, US
Assignee:
A.P. Pharma, Inc. - Redwood City CA
International Classification:
A61K 31/439
A61K 31/435
A61K 31/46
A61K 31/416
A61K 47/30
A61P 1/08
C07D 319/04
US Classification:
424426, 424422, 424425, 424486, 514279, 514337, 514338, 514339, 5147723, 5147727, 549335
Abstract:
A semi-solid delivery vehicle contains a polyorthoester and an excipient, and a semi-solid pharmaceutical composition contains an active agent and the delivery vehicle. The pharmaceutical composition may be a topical, syringable, or injectable formulation; and is suitable for local delivery of the active agent. Methods of treatment are also disclosed.

Semi-Solid Delivery Vehicle And Pharmaceutical Compositions

View page
US Patent:
20050042194, Feb 24, 2005
Filed:
Sep 28, 2004
Appl. No.:
10/953841
Inventors:
Steven Ng - San Francisco CA, US
Hui Shen - Fremont CA, US
Jorge Heller - Woodside CA, US
Assignee:
A.P. PHARMA, INC. - Redwood City CA
International Classification:
A61K031/765
US Classification:
424078300
Abstract:
A semi-solid delivery vehicle contains a polyorthoester and an excipient, and a semi-solid pharmaceutical composition contains an active agent and the delivery vehicle. The pharmaceutical composition may be a topical, syringable, or injectable formulation; and is suitable for local delivery of the active agent. Methods of treatment are also disclosed.

Genome-Scale Analysis Of Aberrant Dna Methylation In Colorectal Cancer

View page
US Patent:
20130065228, Mar 14, 2013
Filed:
Jun 1, 2012
Appl. No.:
13/486988
Inventors:
TOSHINORI HINOUE - ALHAMBRA CA, US
HUI SHEN - SAN GABRIEL CA, US
DANIEL J. WEISENBERGER - LOS ANGELES CA, US
PETER W. LAIRD - SOUTH PASADENA CA, US
Assignee:
UNIVERSITY OF SOUTHERN CALIFORNIA - LOS ANGELES CA
International Classification:
C12Q 1/68
US Classification:
435 611
Abstract:
Particular aspects provide methods and compositions (e.g., gene marker panels) having substantial utility for at least one of diagnosis, identification and classification of colorectal cancer (CRC) (e.g., tumors) relating to distinctive DNA methylation-based subgroups of CRC including CpG island methylator phenotype (CIMP) groups (e.g., CIMP-H and CIMP-L) and non-CIMP groups. Exemplary marker panels include: B3GAT2, FOXL2, KCNK13, RAB31 and SLIT1 (CIMP marker panel); and FAM78A, FSTL1, KCNC1, MYOCD, and SLC6A4 (CIMP-H marker panel). Further aspects relate to genetic mutations, and other epigenetic markers relating to said CRC subgroups that can be used in combination with the gene marker panels for at least one of diagnosis, identification and classification of colorectal cancer (CRC) (e.g., tumors) relating to distinctive CIMP and non-CIMP groups.
Hui Chun Shen from Palo Alto, CA, age ~54 Get Report